High-rise HCare Global Health Industry Summit held! To build a combination of industry, science and research and medicine innovative ecology.

Read: Big Health Industry Finally Has Its Own IP: "HCare". On August 8,
, the main forum of hCare Global Health Industry Summit officially opened.
the big health industry finally has its own IP: "HCare". On August 8,
, the main forum of hCare Global Health Industry Summit officially opened.
this forum, Vice President of the Chinese Academy of Engineering, President of the Beijing Concord Medical College of the Chinese Academy of Medical Sciences, Professor Wang Xiaodong, Director of the Beijing Institute of Life Sciences, Founder of Baiji Shenzhou, Professor Zhang Wenhong, Director of Infection Department of Huashan Hospital, affiliated with Fudan University, and President of Mayo Clinic International. Mr. Anton Decker, together with Mr. Innoqing, Co-Chief Investment Officer and Partner of Gao's, and representatives of the Industry, Science and Technology, gathered to launch a summit dialogue on the future development prospects of the health industry in the post-epidemic era.
from left to right: G. Anton Decker, Wang Xiaodong, Wang Chen, Zhang Wenhong, And Inoqing HCare will be the summit permanent IP 2020, the new crown epidemic is raging around the world, the value of the medical health industry is highlighted. how
speed up biotechnology innovation, improve health care, and accelerate the development of large health industry? The HCare Global Health Industry Summit was born against this backdrop.
to be able to hold such an event, and the global health industry in the layout of the deep cultivation of the deep.
the latest statistics show that Gao Yu has basically completed the global biomedicine, medical equipment, high-end hospitals, pharmaceutical retail and other industry chain coverage, investment in more than 160 enterprises, of which more than 100 Chinese enterprises, the total investment amount of more than 120 billion yuan, the total market value of investment enterprises more than 2.5 trillion yuan.
as a leader in the domestic respiratory medicine industry, Wang Chen expressed his confidence in the future development of the medical and health industries in his speech at the summit.
", "This outbreak has made us more aware that health is a mainstream social cause that is related to people's well-being, economic development and social security and stability."
in the future economic development model, relative to food, clothing and housing and other consumption growth, health-related industry growth space is huge, completely called 'the future of the first major industry'.
," said Wang Chen.
outbreak has not stopped cross-border communication and cooperation in the health industry.
via Transocean video link, the United States Mayo Clinic International President G. Anton Decker says that in the current situation, it is more important to strengthen the global health care industry and research linkage. "Our researchers, including virologists, microbiologists, infectious disease specialists, and critical specialists, learn different information from all over the world every day, conduct scientific research on the new coronavirus, and we need global collaboration in dealing with the new crown outbreak,"
.
", in fact, the outbreak of the new crown outbreak has also objectively accelerated the deep integration between the industry and the medical doctors.
", "Today's health industry is vibrant, just like the year before the explosion of the information industry, the upstream and downstream are taking place more and more intense coupling effect, through the cooperation of industry, research and development, to build an integrated and innovative ecology, will greatly reduce the innovation cost of the entire industry, accelerate the rate of iteration of drug and medical device research and development, create huge incremental value.
" as the host of the HCare Summit, Gao Gao co-chief investment officer and partner Yi Noqing expressed the world's expectations for the integration of medical research and development.
this is exactly what It was to host hCare's Global Health Industry Summit.
", "As in the information industry, Google has I/O conference, Microsoft has Build conference, then our big health industry from today has the HCare summit, 'HCare' will become the conference's permanent IP, become the global health industry partners of the joint secret, become the big health industry integration and innovation horn."
," Mr Inoqing said.
uncovering the latest developments in the global new crown epidemic as a top-level event to focus on the health care industry, the new crown outbreak is an unadendd topic.
Wang Chen said that the new crown outbreak will not soon pass, the future remains uncertain.
" the continuous evolution and variation of different strains of the virus, its transmission and pathogenic dynamic changes, coupled with the transmission of the strains encountered in isolation and other social interventions, vaccines and other scientific and technological interventions, each strain and its resulting outbreak of the 'destiny' will be very different, making the prediction of the outbreak extremely difficult, accurate prediction is almost impossible.
"for the public concern about whether the outbreak will return in the autumn and winter festival", Professor Zhang Wenhong believes that the so-called autumn and winter second wave of the epidemic, is marked by the end of the first wave, now the first wave in the world is not over, so, "second wave of the epidemic" is still a false proposition.
he also stressed that "China's worst moment soning is over, thanks to a more complete anti-epidemic strategy system."
" participants also expressed optimistic consensus that humanity will eventually overcome the virus.
", "from a scientific point of view, if you look back at the past 30 years, humans have basically conquered three very important viruses, hepatitis B, HIV, hepatitis C."
the ability of human scientific research, the community as a whole will pay attention to the new coronavirus, will certainly enable scientists to make vaccines to find efficient treatments.
," said Wang Xiaodong.
vaccines are the best solution when the new crown therapeutic drugs are difficult to come by in the short term. as an important part of this main forum,
has been studying the pharmaceutical and health industry for many years, and has also shared the research on the progress of the global research and development of the new crown vaccine.
he combed through five technical routes for the development of the new crown vaccine -- the inactivated vaccine, the adenovirus vector vaccine, the recombinant protein vaccine, the nucleic acid vaccine (including the mRNA and DNA vaccine) and the detoxification vaccine -- and, on behalf of the company, presented the latest developments in each route.
, mRNA vaccine, the world's first Phase III clinical U.S. biopharmaceutical company (Moderna), the fastest-paced Suzhou Abogen, adeno carrier vaccine representative company Consinothi Bio, and recombinant protein vaccine representative company clover biology, all participated in the CareH Global Health Industry Summit, and appeared at the "New Crown Therapeutic Antibodies and Vaccine Sub-Forum" to share their progress. according to the
public information, based on the long-term deep cultivation in the biopharmaceutical innovation industry, Gao Yu has invested in a number of cutting-edge enterprises in the research and development of new crown vaccines over the years, in addition to Moderna, clover biology, and the Institute of Microbiology of the Chinese Academy of Sciences jointly developed the new crown virus neutralized antibodies, Junshi biological will also attend the "New Crown Therapeutic Antibodies and Vaccine Sub-Forum."
it is worth mentioning that just before the forum, the National Respiratory Medical Center was just established.
, as the director of the medical center, academician Wang Chen was expected to have high hopes.
he also said at the forum that the establishment of the center is an important initiative to promote the development of the national respiratory discipline, the center will develop respiratory disciplines to improve the prevention and treatment of respiratory diseases, including the new crown.
HCare Summit urges the integration of medical products and research as the world's top summit for the big health industry, and the integration of medical products and research is the highlight of this summit.
" to do clinical, research, industry, should be through cross-industry integration, the formation of a strong symphony.
," said Wang Chen.
Zhang Wenhong also believes that many clinical problems, from the front of the basic research, to clinical research, and then products out, need innovation and cross-industry integration to solve.
", "The future for a long time, we have quite a few diseases, will have a look forward to the health industry.
also want to see more Wang Xiaodong academicians from the front end of medical and scientific research to the back end, according to clinical needs to design products, but also look forward to Wang Chen academician-led National Respiratory Medical Center, with the integration of the entire clinical network, for all scientists, industry to empower.
," Mr Zhang said.
In addition to the vertical integration of medical institutions and medical institutions, scientific research and scientific research, industry and industrial end, horizontal communication between medical institutions and medical institutions, scientific research and industrial end is also very important.
in order to bring the global healthcare industry closer together and promote horizontal exchanges between the various industries in the same field, the HCare Summit has designed a main forum and 15 thematic sub-forums.
more than 130 speakers from Asia, the Americas and Europe, bringing 16 live and 40 lectures.
, more than 600 executives, more than 1,000 medical and pharmaceutical companies, more than 1,500 investment institutions, and more than 13,000 registered guests attended the summit.
over the next three days, participants from the global industry and medical community will focus on the global development of new crown vaccines and therapeutic antibodies, the frontiers and advances in cell therapy, innovation and market access for orphan drugs, innovative clinical research practices, opportunities and challenges in gene therapy, the expansion of RNA and mRNA therapy from rare to large-scale indications, cardiovascular interventional devices and clinical applications and other cutting-edge directions in the global healthcare industry.
"We want to bring together the power of the platform to focus on the dreams, needs and aspirations of every scientist, doctor, patient, and entrepreneur in the field of health, and to the ecological prosperity of the global health industry, and the growth of everything."
," Mr Inoqing said.
.